Exide Industries Q1 FY27 Results Analysis: PAT Jumps 27%, EBITDA Margin Expands 19 bps (EXIDEIND)

CompoundingAI Research Updated July 31, 2026 2 min read
Neutral

Exide Industries Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 5,305.05 Cr (+17.63% YoY) and PAT growth of +27.09% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 5,305.05 Cr (+17.63% YoY)
PAT (Q1)Rs. 407.26 Cr (+27.09% YoY)
EBITDA margin12.35% (+19 bps YoY)
EPS (Q1)Rs. 4.79 (+27.06% YoY)
Market capRs. 38,479.50 Cr
CMPRs. 452.70

Quarter Snapshot

Revenue grew 17.6% YoY and PAT 27.1% YoY, with all segments delivering double-digit growth. Operating leverage offset elevated lead costs, resulting in a 19 bps EBITDA margin expansion. The lithium-ion gigafactory remains on track for FY27 revenue, though subsidiary drag and inventory build warrant monitoring.

Key Investment Insights

Key Positives

  • Revenue grew 17.6% YoY to Rs.5,305 Cr.
  • PAT grew 27.1% YoY to Rs.407 Cr.
  • EBITDA margin expanded 19 bps YoY to 12.35%.
  • Automotive OEM battery volumes grew over 25% for third consecutive quarter.
  • Reserve Power segment grew over 20% YoY.
  • International business returned to growth with 20%+ YoY increase.
  • All business segments grew double-digit, indicating broad-based demand.

Risk Factors

  • COGS ratio rose 131 bps YoY to 70.48% due to elevated lead prices and rupee depreciation.
  • Inventory built significantly (Rs.256 Cr build vs Rs.11.5 Cr release last year), indicating working capital pressure.
  • Consolidated PAT was dragged by subsidiary losses of Rs.56.79 Cr from the lithium-ion gigafactory investment.
  • Actuarial losses led to negative OCI of Rs.112.31 Cr, impacting comprehensive income.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now